Concomitant cerebral aspergillosis and mucormycosis in an immunocompetent woman treated with corticosteroids

  • Vittorio ManteroEmail author
  • Paola Basilico
  • Ugo Pozzetti
  • Silvia Tonolo
  • Giorgio Rossi
  • Giannantonio Spena
  • Andrea Rigamonti
  • Andrea Salmaggi
Case Report


We present the case of an immunocompetent 55-year-old woman, treated with corticosteroids, developing a cerebral fungal infection with autoptic ascertainment of aspergillosis and mucormycosis. This is the first report of cerebral co-infection by mucorales and aspergillus in an immunocompetent host. A possible explanation is that corticosteroids, even if taken for a short time, led to a transient lowering of immune function and contributed to negative outcome.


Aspergillosis Mucormycosis Fungal infection Cerebral infection 



  1. Alfano C, Chiummariello S, Dessy LA, Bistoni G, Scuderi N (2006) Combined mucormycosis and aspergillosis of the rhinocerebral region. In Vivo 20:311–315PubMedGoogle Scholar
  2. Chermetz M, Gobbo M, Rupel K, Ottaviani G, Tirelli G, Bussani R, Luzzati R, Di Lenarda R, Biasotto M (2016) Combined orofacial aspergillosis and mucormycosis: fatal complication of a recurrent paediatric glioma-case report and review of literature. Mycopathologia. 181:723–733CrossRefGoogle Scholar
  3. Chong GM, Maertens JA, Lagrou K, Driessen GJ, Cornelissen JJ, Rijnders BJ (2016) Diagnostic performance of galactomannan antigen testing in cerebrospinal fluid. J Clin Microbiol 54:428–431CrossRefGoogle Scholar
  4. Gómez-López A, Cuenca-Estrella M, Monzón A, Rodriguez-Tudela JL (2001) In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole. J Antimicrob Chemother 48:919–921CrossRefGoogle Scholar
  5. Lewis R, Liao G, Wang W, Prince R, Kontoyiannis D (2011) Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection. Virulence 2:348–355CrossRefGoogle Scholar
  6. Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young JA, Bennett JE (2016) Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 63:e1–e60CrossRefGoogle Scholar
  7. Pellacchia V, Terenzi V, Moricca LM, Buonaccorsi S, Indrizzi E, Fini G (2006) Brain abscess by mycotic and bacterial infection in a diabetic patient: clinical report and review of literature. J Craniofac Surg 17:578–584CrossRefGoogle Scholar
  8. Ren Z, Laumann AE, Silverberg JI (2019) Association of dermatomyositis with systemic and opportunistic infections in the United States. Arch Dermatol Res 311:377–387CrossRefGoogle Scholar
  9. Rickerts V, Just-Nübling G, Konrad F, Kern J, Lambrecht E, Böhme A, Jacobi V, Bialek R (2006) Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples. Eur J Clin Microbiol Infect Dis 25:8–13CrossRefGoogle Scholar
  10. Spellberg B, Edwards J Jr, Ibrahim A (2005) Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 18:556–569CrossRefGoogle Scholar
  11. Tripathi M, Mohindra S (2018) Rhinocerebral aspergillosis. Lancet. 392:e8CrossRefGoogle Scholar

Copyright information

© Journal of NeuroVirology, Inc. 2019

Authors and Affiliations

  1. 1.Neurology Unit“A. Manzoni” Hospital – ASST LeccoLeccoItaly
  2. 2.Department of Internal Medicine“A. Manzoni” Hospital – ASST LeccoLeccoItaly
  3. 3.Pathological Anatomy Unit“A. Manzoni” Hospital – ASST LeccoLeccoItaly
  4. 4.Laboratory Unit“A. Manzoni” Hospital – ASST LeccoLeccoItaly
  5. 5.Neurosurgery Unit“A. Manzoni” Hospital – ASST LeccoLeccoItaly

Personalised recommendations